Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert G Cooper

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Rheumatology Advances in Practice|August 22, 2019
Increasing incidence of adult idiopathic inflammatory myopathies in the City of Salford, UK: a 10-year epidemiological studyMatthew J S Parker, Alexander Oldroyd, Mark E Roberts, et al.
Annals of the Rheumatic Diseases|April 5, 2007
Interferon-gamma and interleukin-4 gene polymorphisms in Caucasian idiopathic inflammatory myopathy patients in UKHector Chinoy, Fiona Salway, Sally John, et al.
Arthritis and Rheumatism|November 1, 2008
Reliability and validity of the myositis disease activity assessment toolShabina M Sultan, Elizabeth Allen, Chester V Oddis, et al.
Plos One|March 5, 2013
Association of an MHC class II haplotype with increased risk of polymyositis in Hungarian Vizsla dogsJonathan Massey, Simon Rothwell, Clare Rusbridge, et al.
Rheumatology (Oxford, England)|December 12, 2018
The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositisAlexander Oldroyd, Jamie C Sergeant, Paul New, et al.
Rheumatology (Oxford, England)|August 5, 2019
Comment on: The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis: ReplyAlexander Oldroyd, Jamie C Sergeant, R Paul New, et al.
Rheumatology (Oxford, England)|March 15, 2018
Using serum troponins to screen for cardiac involvement and assess disease activity in the idiopathic inflammatory myopathiesJames B Lilleker, Axel C P Diederichsen, Søren Jacobsen, et al.
Arthritis Research & Therapy|July 9, 2016
Systematic protein-protein interaction and pathway analyses in the idiopathic inflammatory myopathiesJoanna E Parkes, Simon Rothwell, Philip J Day, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 15, 2002
Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humansMattias Soop, Helen Duxbury, Anselm O Agwunobi, et al.
Rheumatology (Oxford, England)|November 30, 2018
The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohortMatthew J S Parker, Alexander Oldroyd, Mark E Roberts, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Rheumatology Advances in Practice|August 22, 2019
Increasing incidence of adult idiopathic inflammatory myopathies in the City of Salford, UK: a 10-year epidemiological studyMatthew J S Parker, Alexander Oldroyd, Mark E Roberts, et al.
Annals of the Rheumatic Diseases|April 5, 2007
Interferon-gamma and interleukin-4 gene polymorphisms in Caucasian idiopathic inflammatory myopathy patients in UKHector Chinoy, Fiona Salway, Sally John, et al.
Arthritis and Rheumatism|November 1, 2008
Reliability and validity of the myositis disease activity assessment toolShabina M Sultan, Elizabeth Allen, Chester V Oddis, et al.
Plos One|March 5, 2013
Association of an MHC class II haplotype with increased risk of polymyositis in Hungarian Vizsla dogsJonathan Massey, Simon Rothwell, Clare Rusbridge, et al.
Rheumatology (Oxford, England)|December 12, 2018
The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositisAlexander Oldroyd, Jamie C Sergeant, Paul New, et al.
Rheumatology (Oxford, England)|August 5, 2019
Comment on: The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis: ReplyAlexander Oldroyd, Jamie C Sergeant, R Paul New, et al.
Rheumatology (Oxford, England)|March 15, 2018
Using serum troponins to screen for cardiac involvement and assess disease activity in the idiopathic inflammatory myopathiesJames B Lilleker, Axel C P Diederichsen, Søren Jacobsen, et al.
Arthritis Research & Therapy|July 9, 2016
Systematic protein-protein interaction and pathway analyses in the idiopathic inflammatory myopathiesJoanna E Parkes, Simon Rothwell, Philip J Day, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 15, 2002
Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humansMattias Soop, Helen Duxbury, Anselm O Agwunobi, et al.
Rheumatology (Oxford, England)|November 30, 2018
The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohortMatthew J S Parker, Alexander Oldroyd, Mark E Roberts, et al.
Pageof 7